|
Volumn 60, Issue 6, 2001, Pages 577-584
|
Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: Procedure related mortality and impact on skin disease
a a a a a a a a a a a a a a a a a a a a more.. |
Author keywords
[No Author keywords available]
|
Indexed keywords
ADULT;
ARTICLE;
AUTOTRANSPLANTATION;
CLINICAL TRIAL;
DISEASE COURSE;
FEMALE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
LUNG FIBROSIS;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
MULTICENTER STUDY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
PULMONARY HYPERTENSION;
SCORING SYSTEM;
SEX RATIO;
SKIN FIBROSIS;
SURVIVAL RATE;
SYSTEMIC SCLEROSIS;
ADOLESCENT;
ADULT;
AUTOIMMUNE DISEASES;
BONE MARROW PURGING;
CHILD;
FEMALE;
HEART;
HEMATOPOIETIC STEM CELL MOBILIZATION;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
KIDNEY;
LUNG;
MALE;
MIDDLE AGED;
SCLERODERMA, SYSTEMIC;
SURVIVAL RATE;
TRANSPLANTATION CONDITIONING;
TRANSPLANTATION, AUTOLOGOUS;
TREATMENT OUTCOME;
|
EID: 0035017415
PISSN: 00034967
EISSN: None
Source Type: Journal
DOI: 10.1136/ard.60.6.577 Document Type: Article |
Times cited : (262)
|
References (30)
|